Impact of Infection Dose and Previous Serum Antibodies against the Locus of Enterocyte Effacement Proteins on Escherichia coli O157:H7 Shedding in Calves following Experimental Infection. (8th June 2015)

• Record Type: Journal Article
• Authors: Martorelli, L.; Hovde, C. J.; Vilte, D. A.; Albanese, A.; Zotta, E.; Ibarra, C.; Cantet, R. J. C.; Mercado, E. C.; Cataldi, A.
• Other Names: Joshi Anjali Academic Editor.
• Is Part Of: BioMed research international. Volume 2015(2015)
• Publication Date: 2015-06-08
• Subjects: Medicine -- Periodicals; Biology -- Periodicals; Biotechnology -- Periodicals; Life sciences -- Periodicals; 610.5
• DOI: 10.1155/2015/290679
• Languages: English
• ISSNs: 2314-6133

Abstract

Abstract : Escherichia coli O157:H7 is the main causative agent of haemolytic uremic syndrome. Cattle are the main reservoir of these bacteria, and have been shown to develop immune response to colonization. Our aim was to investigate the faecal shedding pattern of E. coli O157:H7 in calves challenged intragastrically with either 10 8 or 10 10 CFU, as well as the ability of specific preexisting antibodies to reduce shedding of the pathogen. Shedding was analysed by direct counting as well as enrichment of rectoanal mucosal swabs. Statistical analysis was performed using a linear model for repeated measures with and without the inclusion of preexisting antibodies against the carboxy-terminal fraction of intimin- γ ( γ -intimin C280) as a covariable. Results suggest that there is a statistical difference in the area under the shedding curves between both doses for 14 as well as 28 days after challenge ( p = 0.0069 and 0.0209, resp.). This difference is increased when the prechallenge antibodies are taken into account ( p = 0.0056 and 0.0185). We concluded that the bacterial dose influences shedding on calves experimentally challenged and that preexisting antibodies against E. coli O157:H7 γ -intimin C280 could partially reduce faecal excretion.